Violetta Cotreau - 03 Jan 2022 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
SVP, Chief Accounting Officer
Signature
/s/ Nicole R. Hadas, attorney-in-fact for Violetta Cotreau
Issuer symbol
AKBA
Transactions as of
03 Jan 2022
Net transactions value
-$13,335
Form type
4
Filing time
05 Jan 2022, 15:11:58 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $13,335 -5,833 -15% $2.29 33,067 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of the reporting person's restricted stock units granted on December 31, 2020.